BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.52B |
| 2 |
Visa
V
|
+$442M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$391M |
| 4 |
DuPont de Nemours
DD
|
+$296M |
| 5 |
NVIDIA
NVDA
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$643M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$245M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.29% |
| 2 | Consumer Discretionary | 8.84% |
| 3 | Healthcare | 6.65% |
| 4 | Financials | 5.52% |
| 5 | Industrials | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
InfuSystem Holdings
INFU
$249M
| $46.6K | ﹤0.01% |
4,834
+4,713
| +3,895% | +$42.7K |
|
3377
Unity Bancorp
UNTY
$620M
| $46.4K | ﹤0.01% |
1,967
-1,490
| -43% | -$33.8K |
|
3378
Gevo
GEVO
$401M
| $45.6K | ﹤0.01% |
29,979
-25,333
| -46% | -$32.7K |
|
3379
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.99B
| $45.5K | ﹤0.01% |
964
+628
| +187% | +$29.9K |
|
|
EVBN
3380
DELISTED
Evans Bancorp Inc
EVBN
| $45.4K | ﹤0.01% |
+1,822
| New | +$49.4K |
|
3381
EVI Industries
EVI
$209M
| $45.1K | ﹤0.01% |
2,050
+2,047
| +68,233% | +$41.7K |
|
|
GRTS
3382
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $44.7K | ﹤0.01% |
22,941
+22,307
| +3,518% | +$52.2K |
|
3383
NI Holdings
NODK
$313M
| $44.6K | ﹤0.01% |
3,001
+1,361
| +83% | +$18.5K |
|
3384
CPI Card Group
PMTS
$334M
| $44.5K | ﹤0.01% |
1,914
+14
| +0.7% | +$448 |
|
|
PWOD
3385
DELISTED
Penns Woods Bancorp
PWOD
| $44.5K | ﹤0.01% |
+1,776
| New | +$43.1K |
|
3386
Oak Valley Bancorp
OVLY
$288M
| $44K | ﹤0.01% |
+1,746
| New | +$42.4K |
|
3387
National Bankshares
NKSH
$272M
| $43.8K | ﹤0.01% |
+1,500
| New | +$44.7K |
|
3388
Takeda Pharmaceutical
TAK
$55.5B
| $43.7K | ﹤0.01% |
2,781
+759
| +38% | +$12.4K |
|
3389
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $43.3K | ﹤0.01% |
864
-199,836
| -100% | -$10.1M |
|
3390
Fennec Pharmaceuticals
FENC
$423M
| $43.2K | ﹤0.01% |
4,891
+4,721
| +2,777% | +$39.3K |
|
3391
First Bank
FRBA
$471M
| $43.1K | ﹤0.01% |
4,155
-11,487
| -73% | -$117K |
|
3392
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $43.1K | ﹤0.01% |
+1,403
| New | +$42.8K |
|
3393
First Western Financial
MYFW
$309M
| $42.8K | ﹤0.01% |
2,302
-1,833
| -44% | -$32.1K |
|
3394
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $42.6K | ﹤0.01% |
525
-75,373
| -99% | -$6.16M |
|
|
KZR
3395
DELISTED
Kezar Life Sciences
KZR
| $42.4K | ﹤0.01% |
1,729
-8,526
| -83% | -$222K |
|
3396
DiaMedica Therapeutics
DMAC
$364M
| $42.3K | ﹤0.01% |
9,800
+7,596
| +345% | +$18.4K |
|
3397
Consumer Portfolio Services
CPSS
$208M
| $41.3K | ﹤0.01% |
3,536
-3,064
| -46% | -$33.1K |
|
|
CWBC
3398
Community West Bancshares
CWBC
$706M
| $41K | ﹤0.01% |
2,655
+2,597
| +4,478% | +$40.2K |
|
3399
Altimmune
ALT
$560M
| $41K | ﹤0.01% |
11,610
-327,566
| -97% | -$1.47M |
|
3400
Mammoth Energy Services
TUSK
$154M
| $40.8K | ﹤0.01% |
8,457
+8,074
| +2,108% | +$33.4K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2023 Portfolio in Review
As of Q2 2023, BNP Paribas Financial Markets held 4,079 positions worth $80B, up 12% from $71.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets's Q2 2023 filing shows 263 new, 1,328 increased, 1,932 reduced and 164 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M. The largest sale was Invesco QQQ Trust, an estimated $643M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2023 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M.
- BNP Paribas Financial Markets added most to Alibaba in Q2 2023, an estimated $1.52B increase.
- BNP Paribas Financial Markets's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $643M.
- BNP Paribas Financial Markets fully exited iShares Russell Mid-Cap Growth ETF in Q2 2023, selling an estimated $35.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $80B portfolio in Q2 2023.
- BNP Paribas Financial Markets opened 263 new positions and closed 164 in Q2 2023.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $80B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.